[HTML][HTML] Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for …
M Nouri, E Ratther, N Stylianou, CC Nelson… - Frontiers in …, 2014 - frontiersin.org
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
[PDF][PDF] Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou, CC Nelson, BG Hollier… - researchgate.net
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
[PDF][PDF] Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou, CC Nelson, BG Hollier… - core.ac.uk
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou… - Frontiers in …, 2014 - pubmed.ncbi.nlm.nih.gov
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
[HTML][HTML] Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for …
M Nouri, E Ratther, N Stylianou, CC Nelson… - Frontiers in …, 2014 - ncbi.nlm.nih.gov
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
[PDF][PDF] Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou, CC Nelson, BG Hollier… - minerva-access.unimelb.edu.au
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
[引用][C] Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou… - Frontiers in …, 2014 - espace.library.uq.edu.au
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou, C Nelson… - Frontiers in …, 2014 - eprints.qut.edu.au
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
M Nouri, E Ratther, N Stylianou… - Frontiers in …, 2014 - research.monash.edu
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention.
M Nouri, E Ratther, N Stylianou, CC Nelson… - Frontiers in …, 2014 - europepmc.org
Androgens regulate biological pathways to promote proliferation, differentiation, and survival
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …
of benign and malignant prostate tissue. Androgen receptor (AR) targeted therapies exploit …